| Feb 28, 2025 |
Mar 4, 2025 |
Aurinia Pharmaceuticals Inc.
|
EVP, General Counsel |
Sell |
97.5
|
+64,033
|
14.38%
|
✗
|
$975.2K |
| Mar 6, 2024 |
Mar 7, 2024 |
Aurinia Pharmaceuticals Inc.
|
EVP, General Counsel |
Sell |
40.0
|
-57,745
|
-11.51%
|
✗
|
$323.4K |
| Mar 2, 2023 |
Feb 22, 2024 |
Aurinia Pharmaceuticals Inc.
|
EVP, General Counsel |
Sell |
42.5
|
-19,644
|
-6.09%
|
✗
|
$172.5K |
| Mar 2, 2023 |
Mar 6, 2023 |
Aurinia Pharmaceuticals Inc.
|
EVP, General Counsel |
Sell |
95.0
|
+185,408
|
157.18%
|
✗
|
$173.5K |
| Jan 28, 2021 |
Jan 29, 2021 |
Aurinia Pharmaceuticals Inc.
|
EVP, General Counsel |
Buy |
91.3
|
+900
|
49.45%
|
✗
|
$14.5K |